Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Hyprotek Inc
Profile last edited on: 10/21/2021      CAGE: 62ND7      UEI: TLBWL35F22K3

Business Identifier: Improve safety and efficiency of intravenous therapy
Year Founded
2010
First Award
2020
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

665 North Riverpoint Boulevard
Spokane, WA 99202
   (509) 543-3020
   N/A
   hyprotekinc.com/contact/
Location: Single
Congr. District: 05
County: Spokane

Public Profile

Hyprotek, Inc. is a biomedical company develops patented medical technologies designed to improve the safety and efficiency of intravenous therapy. principals of the firm have developed two patent-pending medical device systems designed significantly to reduce the risk of patient infections in the clinical setting.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$251,572
Phase II Dollars
$0
Total Awarded
$251,572

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 1 NIH $251,572
Project Title: Intravascular Port and Disinfection System (Portprotek)

Key People / Management

  Patrick O Tennican -- CEO and President

Company News

There are no news available.